These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6217027)

  • 21. Contact allergy to di-isopropyl sebacate in Zineryt lotion.
    de Groot AC; Conemans JM; Schutte T
    Contact Dermatitis; 1991 Oct; 25(4):260-1. PubMed ID: 1839272
    [No Abstract]   [Full Text] [Related]  

  • 22. The safety of topically applied clindamycin for acne.
    Fisher AA
    Cutis; 1979 Apr; 23(4):406, 416-8, 522. PubMed ID: 154993
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
    Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
    Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study.
    Kircik LH; Peredo MI; Bucko AD; Loss RW; Fowler JF; Wortzman M; Neumaier GJ
    Cutis; 2008 Nov; 82(5):358-66. PubMed ID: 19090341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facial contact dermatitis due to spironolactone in an anti-acne cream.
    Vincenzi C; Trevisi P; Farina P; Stinchi C; Tosti A
    Contact Dermatitis; 1993 Nov; 29(5):277-8. PubMed ID: 8112074
    [No Abstract]   [Full Text] [Related]  

  • 26. Benzoyl peroxide contact allergy in leg ulcer patients.
    Agathos M; Bandmann HJ
    Contact Dermatitis; 1984 Nov; 11(5):316-7. PubMed ID: 6241126
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Clindamycin-associated colitis.
    Wolfe MS
    JAMA; 1974 Jul; 229(3):266-7. PubMed ID: 4275733
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris.
    Leyden JJ; Shalita AR; Saatjian GD; Sefton J
    J Am Acad Dermatol; 1987 Apr; 16(4):822-7. PubMed ID: 2952685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nickel allergy and spectacle frame contact acne.
    Grimalt F; Romaguera C
    Contact Dermatitis; 1978 Dec; 4(6):377. PubMed ID: 153824
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical clindamycin-associated diarrhea. Case report and review of the literature.
    Schiedermayer DL; Loo FD
    Wis Med J; 1987 Mar; 86(3):29-30. PubMed ID: 2951927
    [No Abstract]   [Full Text] [Related]  

  • 32. Is benzoyl peroxide an irritant or sensitizer?
    Mora Morillas I; Aguilar Martinez A; Sanchez Lozano JL; Garcia Pérez A
    Contact Dermatitis; 1987 Apr; 16(4):232-3. PubMed ID: 2954766
    [No Abstract]   [Full Text] [Related]  

  • 33. Clindamycin-tretinoin (veltin gel) for acne.
    Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):102-3. PubMed ID: 21150834
    [No Abstract]   [Full Text] [Related]  

  • 34. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
    Kircik LH
    J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Jackson JM; Fu JJ; Almekinder JL
    J Drugs Dermatol; 2010 Feb; 9(2):131-6. PubMed ID: 20214175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic absorption of topical clindamycin.
    Voron DA
    Arch Dermatol; 1978 May; 114(5):798. PubMed ID: 148241
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colitis associated with clindamycin.
    Med Lett Drugs Ther; 1974 Aug; 16(18):73-4. PubMed ID: 4277410
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison.
    Shahlita AR; Smith EB; Bauer E
    Arch Dermatol; 1984 Mar; 120(3):351-5. PubMed ID: 6230999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.